| Line Item | 2025-09-26 | Y/Y |
|---|---|---|
| Revenue | $1.35B | +5.9% |
| Cost of Revenue | $160.1M | +14.0% |
| Gross Profit | $1.19B | +4.9% |
| R&D Expense | $261.8M | -0.7% |
| SG&A Expense | $286.5M | +6.0% |
| Operating Income | $265.0M | +2.6% |
| Pre-tax Income | $303.5M | -2.9% |
| Income Tax | $47.0M | -2.4% |
| Net Income | $255.0M |
| Line Item | 2025-09-26 | Y/Y |
|---|---|---|
| Cash & Equivalents | $701.9M | +45.6% |
| Short-term Investments | $703K | — |
| Accounts Receivable | $331.1M | +5.0% |
| Inventory | $30.4M | -9.8% |
| Current Assets | $1.39B | +16.2% |
| Total Assets | $3.23B | +3.8% |
| Current Liabilities | $437.8M | +4.8% |
| Line Item | 2025-09-26 | Y/Y |
|---|---|---|
| Operating Cash Flow | $472.2M | +44.3% |
| Capital Expenditures | $36.3M | +21.1% |
| Investing Cash Flow | -$10.6M | +96.3% |
| Financing Cash Flow | -$247.2M | +14.1% |
| Free Cash Flow | $435.9M | +46.6% |
| -2.6% |
| EPS (Basic) | $2.66 | -2.9% |
| EPS (Diluted) | $2.62 | -2.6% |
| Total Liabilities |
| $595.8M |
| -4.4% |
| Stockholders' Equity | $2.62B | +5.9% |